| Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) JC Goldsack, A Coravos, JP Bakker, B Bent, AV Dowling, C Fitzer-Attas, ... npj digital Medicine 3 (1), 55, 2020 | 294 | 2020 |
| Developing and adopting safe and effective digital biomarkers to improve patient outcomes A Coravos, S Khozin, KD Mandl NPJ digital medicine 2 (1), 14, 2019 | 265 | 2019 |
| Digital medicine: a primer on measurement A Coravos, JC Goldsack, DR Karlin, C Nebeker, E Perakslis, ... Digital biomarkers 3 (2), 31-71, 2019 | 137 | 2019 |
| Decentralized trials in the age of real-world evidence and inclusivity in clinical investigations S Khozin, A Coravos Clin Pharmacol Ther 106 (1), 25-27, 2019 | 101 | 2019 |
| Quantifying the use of connected digital products in clinical research C Marra, JL Chen, A Coravos, AD Stern NPJ digital medicine 3 (1), 50, 2020 | 87 | 2020 |
| Modernizing and designing evaluation frameworks for connected sensor technologies in medicine A Coravos, M Doerr, J Goldsack, C Manta, M Shervey, B Woods, ... NPJ digital medicine 3 (1), 37, 2020 | 73 | 2020 |
| An evaluation of biometric monitoring technologies for vital signs in the era of COVID‐19 C Manta, SS Jain, A Coravos, D Mendelsohn, ES Izmailova Clinical and translational science 13 (6), 1034-1044, 2020 | 56 | 2020 |
| A systematic review of feasibility studies promoting the use of mobile technologies in clinical research JP Bakker, JC Goldsack, M Clarke, A Coravos, C Geoghegan, A Godfrey, ... NPJ digital medicine 2 (1), 47, 2019 | 50 | 2019 |
| Building resilient medical technology supply chains with a software bill of materials S Carmody, A Coravos, G Fahs, A Hatch, J Medina, B Woods, J Corman NPJ Digital Medicine 4 (1), 1-6, 2021 | 29 | 2021 |
| The case for a hippocratic oath for connected medical devices B Woods, A Coravos, JD Corman Journal of Medical Internet Research 21 (3), e12568, 2019 | 29 | 2019 |
| Is health-care data the new blood? E Perakslis, A Coravos The Lancet Digital Health 1 (1), e8-e9, 2019 | 23 | 2019 |
| BioMeT and algorithm challenges: a proposed digital standardized evaluation framework A Godfrey, JC Goldsack, P Tenaerts, A Coravos, C Aranda, A Hussain, ... IEEE Journal of Translational Engineering in Health and Medicine 8, 1-8, 2020 | 17 | 2020 |
| We should treat algorithms like prescription drugs A Coravos, I Chen, A Gordhandas, AD Stern Quartz, 2019 | 11 | 2019 |
| Measuring the Likelihood of Small Business Loan Default AR Coravos Duke University, 2010 | 9 | 2010 |
| Ushering in safe, effective, secure, and ethical medicine in the digital era WJ Gordon, AR Coravos, AD Stern NPJ Digital Medicine 4 (1), 56, 2021 | 7 | 2021 |
| Fast Facts: Digital Medicine-Measurement A Coravos, JC Goldsack, DR Karlin, C Nebeker, E Perakslis, ... Karger Medical and Scientific Publishers, 2020 | 7 | 2020 |
| Connected medical technology and cybersecurity informed consent: A new paradigm J Tully, A Coravos, M Doerr, C Dameff Journal of Medical Internet Research 22 (3), e17612, 2020 | 5 | 2020 |
| The role of digital clinical measures in improving cancer care and research. J Goldsack, A Aguilo, A Coravos, C Economos, K Lyden Journal of Clinical Oncology 39 (15_suppl), e13584-e13584, 2021 | 4 | 2021 |
| Developing and adopting safe and effective digital biomarkers to improve patient outcomes. npj Digit Med. 2019; 2: 1–5 A Coravos, S Khozin, KD Mandl | 2 | |
| Remote digital health technologies for improving the care of people with respiratory disorders J Dunn, A Coravos, M Fanarjian, GS Ginsburg, SR Steinhubl The Lancet Digital Health 6 (4), e291-e298, 2024 | 1 | 2024 |
Eric PerakslisDuke University, Harvard Medical School在 duke.edu 的电子邮件经过验证
